Nippon Shikizai, Inc.
FY2027 Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)
Net sales increased 14.0% year-over-year to 9,155 million yen, operating income was 50 million yen (down 54.4% YoY), and interim net loss was -21 million yen. Full-year forecast remains net sales 18,328 million yen, operating income 261 million yen, net income 100 million yen. Earnings presentation scheduled; dividend forecast is 30 yen per year (at Q2-end), etc.
Key Figures
- Net Sales: 9,155 million yen (14.0% increase YoY)
- Operating Income: 50 million yen (-54.4% YoY)
- Net Income Attributable to Owners of Parent (interim): -21 million yen
AI要約
Overview of Results
In the second quarter (interim) of FY2027, net sales increased to 9,155 million yen (14.0% increase YoY). However, sustained high raw material and labor costs caused continued cost increases, resulting in operating income of 50 million yen (down 54.4% YoY). Ordinary loss amounted to 14 million yen, and net loss attributable to owners of the parent for the interim period was 21 million yen. The full-year forecast is maintained at net sales of 18,328 million yen, operating income of 261 million yen, and net income of 100 million yen, assuming continued inflation and cost pressures.
Outlook and Key Points
The company will steadily execute measures under the Medium-Term Business Strategy Vision (2022-2026). While cosmetic demand is expected to continue recovering, attention must be paid to geopolitical tensions in the Middle East, rising raw material and labor costs, and currency and interest rate movements. Pharmaceutical and cosmetic orders are showing signs of recovery in Europe, whereas the domestic market is impacted by the postponement of new product launches.
Nippon Shikizai, Inc.
Company overview · Stock price · Financial data · All IR
